Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Onyia Jude received 3,587 Neurocrine Biosciences, Inc. shares as an award (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Onyia Jude (Chief Scientific Officer) received 3,587 Neurocrine Biosciences, Inc. shares as an award, leaving 22,647 shares. Filed Sep 15, 2026 (Form 4).
- Awarded
- 3,587 shares
- Holding after
- 22,647 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 3,587 | 24,583 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 1,936 | US$156.22 | 22,647 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Onyia Jude
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Onyia Jude · Aug 5, 2026
- Form 4 · Onyia Jude · Jun 9, 2026
- Form 4 · Onyia Jude · Jun 2, 2026
- Form 4 · Onyia Jude · May 29, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Lippoldt Darin · Sep 15, 2026